AMBER WITTKE: Open Payments
NPI 1467935908 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 24 payments from 8 companies in 2025. Trend: 2023 $522 · 2024 $260 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $221 |
| Astellas Pharma US Inc | 3 | $94 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $61 |
| MILLICENT US INC | 2 | $34 |
| Exeltis, USA Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Organon LLC | 1 | $9 |
Products named: ZURZUVAE, Veozah, FEMLYV, SLYND, Auvelity, ABRYSVO, NEXPLANON.
Industry payments across IN — which companies pay providers there.
